Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-19

Clinical Trial Update: Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

View source ↗

Summary

This clinical trial update notes the recruitment of participants to study telitacicept for systemic lupus erythematosus, evaluating its safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telitacicept

Snippet

Sponsor: Tongji Hospital | Conditions: Systemic Lupus Erythematosus | Status: RECRUITING